Clinical Trial Update: A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating AND017 for anemia in non-dialysis-dependent chronic kidney disease and is currently recruiting. Sponsored by Kind Pharmaceuticals …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia Due to Chronic Kidney Disease

Drugs mentioned

• AND017

Snippet

Sponsor: Kind Pharmaceuticals LLC | Conditions: Anemia Due to Chronic Kidney Disease | Phase 3 | Status: RECRUITING